A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery
Drug and target discovery for advanced liver disease are hampered by a lack of suitable models for clinical translation. Here the authors present a human liver cell-based system modeling a clinical prognostic signature allowing to propose nizatidine for treatment of advanced liver fibrosis and hepat...
Enregistré dans:
Documents similaires
-
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor
par: Carla Eller, et autres
Publié: (2020) -
Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
par: Gwyneth Shook Ting Soon, et autres
Publié: (2021) -
Liver
Publié: (1981) -
Augmenter of liver regeneration (alr) promotes liver outgrowth during zebrafish hepatogenesis.
par: Yan Li, et autres
Publié: (2012) -
Genome-wide association study of serum liver enzymes implicates diverse metabolic and liver pathology
par: Vincent L. Chen, et autres
Publié: (2021)